![Janet Hammond](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Janet Hammond
Corporate Officer/Principal bei
ATEA PHARMACEUTICALS, INC.
Vermögen: 600 026 $ am 31.07.2026
Profil
Janet Hammond is currently Director at Enterprise Therapeutics Ltd. since 2024, Chief Development Officer at Atea Pharmaceuticals, Inc. since 2020, and Vice President-Translational Medicine at Roche Ltd. since 2011.
Former positions include Group Director-Virology Clinical Research at Bristol Myers Squibb Co., Chief Medical Officer, SVP & Head-Medical Affairs at Bausch Health Americas, Inc., SVP & Head-China Infectious Disease at F.
Hoffmann-La Roche Ltd. from 2011 to 2016, Chief Medical Officer, SVP & Head-Medical Affairs at Valeant Pharmaceutical, VP, Head-General Medicine & Infectious Disease at AbbVie, Inc. from 2016 to 2020, Head-Clinical Discovery at GSK Plc, and Senior Clinical Research Physician at Glaxo Wellcome, Inc. Education includes a doctorate from the University of Cape Town and graduate studies at Johns Hopkins Bloomberg School of Public Health.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 24.04.2026 | 127’665 ( 0.16% ) | 600 026 $ | 31.07.2026 |
Aktive Positionen von Janet Hammond
| Unternehmen | Position | Beginn |
|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.08.2020 |
Roche Ltd.
 Roche Ltd. Financial ConglomeratesFinance Provides investment services | Corporate Officer/Principal | 29.03.2011 |
Enterprise Therapeutics Ltd.
 Enterprise Therapeutics Ltd. BiotechnologyHealth Technology Develops novel therapies to patients suffering with respiratory diseases | Direktor/Vorstandsmitglied | 01.05.2024 |
Ehemalige bekannte Positionen von Janet Hammond
| Unternehmen | Position | Ende |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 01.08.2020 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.11.2016 |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Technik-/Wissenschafts-/F&E-Leiter | 12.09.2011 |
Valeant Pharmaceutical | Technik-/Wissenschafts-/F&E-Leiter | - |
| BRISTOL-MYERS SQUIBB COMPANY | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Janet Hammond
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
81
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Atea Pharmaceuticals, Inc.
 Atea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes antiviral therapeutics | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Cape Town
 University of Cape Town Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Ltd.
Roche Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Glaxo Wellcome, Inc.
 Glaxo Wellcome, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
Johns Hopkins Bloomberg School of Public Health
 Johns Hopkins Bloomberg School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enterprise Therapeutics Ltd.
Enterprise Therapeutics Ltd. BiotechnologyHealth Technology Develops novel therapies to patients suffering with respiratory diseases | Health Technology |
Valeant Pharmaceutical |
